These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12938870)

  • 1. Re: Thioridazine: re-evaluating the risk/benefit equation.
    Timell AM
    Ann Clin Psychiatry; 2003 Jun; 15(2):131. PubMed ID: 12938870
    [No Abstract]   [Full Text] [Related]  

  • 2. Antipsychotic medications and cardiac conduction risks.
    Roman M; Farmer SY
    Issues Ment Health Nurs; 2010 Jan; 31(1):68-70. PubMed ID: 19951166
    [No Abstract]   [Full Text] [Related]  

  • 3. [Thioridazine and the warning about prolonged QT time].
    Laisalmi M
    Duodecim; 2002; 118(24):2518. PubMed ID: 12572286
    [No Abstract]   [Full Text] [Related]  

  • 4. Concomitant use of antipsychotics with risperidone.
    Chouinard G
    Am J Health Syst Pharm; 1996 Feb; 53(4):443. PubMed ID: 8673669
    [No Abstract]   [Full Text] [Related]  

  • 5. Prolongation of QTc interval and antipsychotics.
    Taylor DM
    Am J Psychiatry; 2002 Jun; 159(6):1062; author reply 1064. PubMed ID: 12042205
    [No Abstract]   [Full Text] [Related]  

  • 6. Thioridazine inhibits risperidone metabolism: a clinically relevant drug interaction.
    Nakagami T; Yasui-Furukori N; Saito M; Mihara K; De Vries R; Kondo T; Kaneko S
    J Clin Psychopharmacol; 2005 Feb; 25(1):89-91. PubMed ID: 15643105
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiotoxicity and prescription of thioridazine in New Zealand.
    Menkes DB; Knight JC
    Aust N Z J Psychiatry; 2002 Aug; 36(4):492-8. PubMed ID: 12169148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition.
    Harrigan EP; Miceli JJ; Anziano R; Watsky E; Reeves KR; Cutler NR; Sramek J; Shiovitz T; Middle M
    J Clin Psychopharmacol; 2004 Feb; 24(1):62-9. PubMed ID: 14709949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of thioridazine and mesoridazine on the QT interval in healthy adults after single oral doses.
    Salih IS; Thanacoody RH; McKay GA; Thomas SH
    Clin Pharmacol Ther; 2007 Nov; 82(5):548-54. PubMed ID: 17410120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged QT Risk Assessment in Antipsychotic Overdose Using the QT Nomogram.
    Berling I; Isbister GK
    Ann Emerg Med; 2015 Aug; 66(2):154-64. PubMed ID: 25639523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolongation of QTc interval and antipsychotics.
    Su KP; Chang HC; Shen WW
    Am J Psychiatry; 2002 Jun; 159(6):1062-3; author reply 1064. PubMed ID: 12042204
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of the CSM advice on thioridazine on general practitioner prescribing behaviour in Leeds: time series analysis.
    Wright NM; Roberts AJ; Allgar VL; Tompkins CN; Greenwood DC; Laurence G
    Br J Gen Pract; 2004 May; 54(502):370-3. PubMed ID: 15113522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Polymorphic ventricular tachycardia of torsade de pointes type in patient with schizophrenia treated with thioridazine].
    Sinkiewicz W; Balak W; Fares I; Karasek D; Małyszka P; Papke M
    Pol Arch Med Wewn; 2006 Dec; 116(6):1188-91. PubMed ID: 18634530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Risperidone use in child and adolescent psychiatric patients].
    Chevreuil C; Reymann JM; Frémaux T; Polard E; Séveno T; Bentué-Ferrer D
    Therapie; 2008; 63(5):359-75. PubMed ID: 19154706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk of antipsychotic-related QT prolongation during nighttime: a 24-hour holter electrocardiogram recording study.
    Watanabe J; Suzuki Y; Fukui N; Ono S; Sugai T; Tsuneyama N; Someya T
    J Clin Psychopharmacol; 2012 Feb; 32(1):18-22. PubMed ID: 22198445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thioridazine: re-evaluating the risk/benefit equation.
    Timell AM
    Ann Clin Psychiatry; 2000 Sep; 12(3):147-51. PubMed ID: 10984004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sudden death in a patient taking antipsychotic drugs.
    Hauben M
    Postgrad Med J; 1999 Feb; 75(880):127. PubMed ID: 10448485
    [No Abstract]   [Full Text] [Related]  

  • 18. Antipsychotic drugs and QT interval prolongation.
    Zareba W; Lin DA
    Psychiatr Q; 2003; 74(3):291-306. PubMed ID: 12918603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac function in patients treated with phenothiazines. Comparison with quinidine.
    Samet JM; Surawicz B
    J Clin Pharmacol; 1974; 14(11-12):588-96. PubMed ID: 4154951
    [No Abstract]   [Full Text] [Related]  

  • 20. QTc interval lengthening is related to CYP2D6 hydroxylation capacity and plasma concentration of thioridazine in patients.
    LLerena A; Berecz R; de la Rubia A; Dorado P
    J Psychopharmacol; 2002 Dec; 16(4):361-4. PubMed ID: 12503836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.